Clinical Trial Update: Toripalimab Combined With Chemotherapy as Adjuvant Therapy for Incidental Small Cell Lung Cancer After Radical Resection of Lung Cancer: A Single-Center, Randomized Controlled Clinical Study Protocol Number: LungMate-033 [Phase 2]

View source ↗

Summary

This is a Phase 2 randomized study protocol evaluating toripalimab plus chemotherapy as adjuvant therapy after radical resection for postoperative incidental sm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China | Conditions: Postoperative Incidental Small Cell Lung Cancer, Toripalimab Adjuvant Therapy Evaluation | Phase 2 | Status: NOT_YET_RECRUITING